A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Droxidopa Impurity 30 | CAS 92-89-7 - Request Quote

Picture of Droxidopa Impurity 30

Droxidopa Impurity 30

SZ CAT No:SZ-D057039
CAS No
92-89-7
Mol.F.
C13H9NO4
Mol.Wt.
243.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Droxidopa Impurity 30 is chemically 4'-Nitro-[1,1'-biphenyl]-4-carboxylic acid. Droxidopa Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Droxidopa Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Droxidopa.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 92-89-7

Purchase 92-89-7

Order 92-89-7

Enquire 92-89-7

price of 92-89-7

92-89-7 Supplier

92-89-7 Manufacturer

92-89-7 Exporter

buy high quality Droxidopa Impurity 30

Purchase Droxidopa Impurity 30

Droxidopa Impurity 30 suppliers

Droxidopa Impurity 30 manufacturers

Droxidopa Impurity 30 price

Order Droxidopa Impurity 30

Enquire Droxidopa Impurity 30

Droxidopa Impurity 30 cost

Droxidopa Impurity 30 Supplier

Droxidopa Impurity 30 Distributor

Droxidopa Impurity 30 for Method Validation

Droxidopa Reference Standard

Droxidopa Impurity 30 for ANDA Filing

Droxidopa Impurity 30 for Forced Degradation Studies

Droxidopa Impurity 30 Identification Standards

Droxidopa Impurity 30 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,